Alpha Cognition (ACOG) Notes Payables (2023 - 2024)
Alpha Cognition (ACOG) posted quarterly Notes Payables of $911463.0 for Q4 2024, down 24.76% year-over-year from $1.2 million in Q1 2024, and down 24.76% quarter-over-quarter from $1.2 million in Q3 2024.
Alpha Cognition (ACOG) Notes Payables (2023 - 2024) Analysis & Trends
Alpha Cognition's Notes Payables history runs 2 years deep, the most recent figure standing at $911463.0 for Q4 2024.
- In Q4 2024, Notes Payables fell 24.76% year-over-year to $911463.0; the TTM figure through Dec 2024 stood at $911463.0 (down 24.76% YoY), while the FY2024 annual figure was $911463.0, down 24.76% from the prior year.
- Notes Payables for Q4 2024 stood at $911463.0, down from $1.2 million in the prior quarter.
- The five-year high for Notes Payables was $1.2 million in Q4 2023, with the low at $300000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Alpha Cognition | 205.66 Mn | 164.21 Mn | 5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 911,463.00 |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 1.21 Mn |